All Pharma News
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA

Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA
ACCESSWIRE
05 Feb 2024
Share Share
Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement
ACCESSWIRE
02 Jan 2024
Share Share
Ainos, Nisshinbo Micro Devices and Inabata Initiate Ph 2 of VOC Co-development

Ainos, Nisshinbo Micro Devices and Inabata Initiate Ph 2 of VOC Co-development
ACCESSWIRE
26 Dec 2023
Share Share
Ainos, Inc. Announces Stock Consolidation

Ainos, Inc. Announces Stock Consolidation
ACCESSWIRE
12 Dec 2023
Share Share
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch

Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch
ACCESSWIRE
28 Nov 2023
Share Share
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA

Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA
ACCESSWIRE
21 Nov 2023
Share Share
Ainos Reports Third Quarter 2023 Financial Results

Ainos Reports Third Quarter 2023 Financial Results
ACCESSWIRE
09 Nov 2023
Share Share
Ainos Signs MoU for Contract Trials to Conduct Clinical Study of VELDONA

Ainos Signs MoU for Contract Trials to Conduct Clinical Study of VELDONA
ACCESSWIRE
06 Nov 2023
Share Share
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million

Ainos Announces Placement of Initial $3 Million Tranche of $10 Million
ACCESSWIRE
25 Sep 2023
Share Share
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA

Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA
ACCESSWIRE
18 Sep 2023
Share Share